D. Lalka

发表

Comparison of chromatographic and spectrophotometric analysis of indocyanine green in plasma following administration of multiple doses to humans.

E. Middleton, D. Edwards, P. M. Mauriello, 1982, Journal of pharmaceutical sciences.

Individualization of phenytoin dosage regimens

T. Ludden, J. McNay, D. Lalka, 1977, Clinical pharmacology and therapeutics.

Pulmonary Disease and Drug Kinetics

M. Gibaldi, A. Mclean, P. Souich, 1978, Clinical pharmacokinetics.

Disopyramide pharmacokinetics and metabolism: effect of inducers.

R. Kapil, C. Kerr, D. Edwards, 1987, British journal of clinical pharmacology.

Clinical Pharmacokinetics of Pethidine: 1982

D. Edwards, C. K. Svensson, D. Lalka, 1982, Clinical pharmacokinetics.

Effect of food on lidocaine kinetics: Mechanism of food‐related alteration in high intrinsic clearance drug elimination

D. Lalka, A. Elvin, J. Pieper, 1981, Clinical pharmacology and therapeutics.

Effect of food on hepatic blood flow: Implications in the “food effect” phenomenon

E. Middleton, R. Lanc, D. Edwards, 1983, Clinical pharmacology and therapeutics.

Effect of smoking on binding of lidocaine to human serum proteins.

P. McNamara, J. Siegel, R. Slaughter, 1980, Journal of pharmaceutical sciences.

Transdermal application of lovastatin to rats causes profound increases in bone formation and plasma concentrations

G. Mundy, G. Rossini, G. Gutierrez, 2006, Osteoporosis International.

Multiple bolus technique for lidocaine administration during the first hours of an acute myocardial infarction.

L. Hammersmith, B. Goldreyer, D. Lalka, 1978, The American journal of cardiology.

Influence of food on the presystemic metabolism of drugs.

A. Melander, A. Mclean, D. Lalka, 1988, Pharmacology & therapeutics.

Lack of effect of smoking on the metabolism and pharmacokinetics of quinidine in patients.

R. Slaughter, D. Edwards, D. Lalka, 1987, British journal of clinical pharmacology.

Nonlinear pharmacokinetics of indocyanine green in the rabbit and rat

P. McNamara, M. Gibaldi, A. Mclean, 1980, Journal of Pharmacokinetics and Biopharmaceutics.

Indocyanine green: pharmacokinetics in the rabbit and relevant studies of its stability and purity.

C. K. Svensson, D. Lalka, R. Heintz, 1986, Journal of pharmaceutical sciences.

Effect of carbohydrates on estimated hepatic blood flow

E. Middleton, P. M. Mauriello, C. K. Svensson, 1984, Clinical pharmacology and therapeutics.

Tocainide protein binding in normal volunteers and trauma patients.

D. Lalka, J. Axelson, A. Elvin, 1982, British journal of clinical pharmacology.

Cyclophosphamide, 2,2-dimethylaziridines and other alkylating agents as inhibitors of serum cholinesterase.

D. Lalka, T. Bardos, 1975, Biochemical pharmacology.

Influence of posture on hepatic perfusion and the presystemic biotransformation of propranolol: simulation of the food effect

J. Hassett, D. Lalka, M. Modi, 1988, Clinical pharmacology and therapeutics.

The pharmacokinetics of meperidine in acute trauma patients.

J. Hassett, R. Slaughter, D. Edwards, 1986, The Journal of trauma.

Factors Affecting Quinidine Protein Binding in Humans

R. Slaughter, D. Edwards, D. Lalka, 1984 .

Alpha1‐acid glycoprotein concentration and protein binding in trauma

F. Cerra, R. Slaughter, D. Edwards, 1982, Clinical pharmacology and therapeutics.

Pharmacokinetics of D‐propranolol following oral, intra‐arterial and intraportal administration: Contrasting effects of oral glucose pretreatment

H. Chow, D. Lalka, H. Chow, 1993, Biopharmaceutics & drug disposition.

Microdetermination of procainamide in human serum.

I. Dávila, T. Ludden, K. Haegele, 1978, Journal of pharmaceutical sciences.

Multiple bolus technique for lidocaine administration in acute ischemic heart disease. II. Treatment of refractory ventricular arrhythmias and the pharmacokinetic significance of severe left ventricular failure.

R. Slaughter, B. Goldreyer, D. Lalka, 1983, Journal of the American College of Cardiology.

Reversed-phase high-performance liquid chromatographic assay to quantitate diastereomeric derivatives of metoprolol enantiomers in plasma.

F. Gengo, D. Lalka, D. Schuster, 1988, Journal of chromatography.

Determination of hydralazine and its metabolites by gas chromatography-mass spectrometry.

K. Haegele, J. McNay, D. Lalka, 1976, Journal of chromatography.

The high voltage paper electrophoresis of kinin peptides K9, K10, and K11.

N. Back, D. Lalka, 1971, Biochimica et Biophysica Acta.

Tocainide conjugation in humans: novel biotransformation pathway for a primary amine.

R. Ronfeld, D. Lalka, A. Elvin, 1980, Journal of pharmaceutical sciences.

Effect of High‐Dose Vitamin C on the Steady‐State Pharmacokinetics of the Protease Inhibitor Indinavir in Healthy Volunteers

G. Hobbs, M. Fisher, R. Khakoo, 2003, Pharmacotherapy.

Free Drug Concentration Monitoring in Clinical Practice

M. Woodruff, C. K. Svensson, D. Lalka, 1986 .

Ampicillin Vs. Penicillin for In Utero Therapy

D. Lalka, D. D. Glover, G. Monif, 1996, Infectious diseases in obstetrics and gynecology.

Ampicillin vs. Penicillin for in utero therapy.

D. Lalka, D. D. Glover, G. Monif, 1996 .

Endogenous accumulation products and serum protein binding in uremia.

P. McNamara, M. Gibaldi, D. Lalka, 1981, The Journal of laboratory and clinical medicine.

Factors Influencing Serum Protein Binding of Lidocaine in Humans

P. McNamara, R. Slaughter, D. Lalka, 1981, Anesthesia and analgesia.

Effect of cimetidine on the pharmacokinetics and pharmacodynamics of quinidine.

Jerome J. Schentag, D. Lalka, B. Hardy, 1983, The American journal of cardiology.

Free drug concentration monitoring in clinical practice. Rationale and current status.

M. Woodruff, C. K. Svensson, D. Lalka, 1986, Clinical pharmacokinetics.

Species differences in the urinary excretion of the novel primary amine conjugate: tocainide carbamoyl O-beta-D-glucuronide.

D. Lalka, J. Axelson, A. Elvin, 1982, Journal of pharmaceutical sciences.

Reactions of 2,2-dimethylaziridine-type alkylating agents in biological systems. I. Colorimetric estimation and stability in physiological media.

D. Lalka, T. Bardos, 1973, Journal of pharmaceutical sciences.

Reactions of 2,2-dimethylaziridine-type alkylating agents in biological systems II: comparative pharmacokinetics in dogs.

W. Jusko, D. Lalka, T. Bardos, 1975, Journal of Pharmacy and Science.

Displacement of lidocaine from serumα1-acid glycoprotein binding sites by basic drugs

R. Slaughter, D. Edwards, D. Lalka, 2004, European Journal of Clinical Pharmacology.

Food, splanchnic blood flow, and bioavailability of drugs subject to first‐pass metabolism

P. McNamara, M. Gibaldi, A. Mclean, 1978, Clinical pharmacology and therapeutics.

Dose-dependent pharmacokinetic behavior of lidocaine in the conscious dog.

A. Mclean, P. du Souich, J. McNay, 1978, Research communications in chemical pathology and pharmacology.

Bupivacaine and other amide local anesthetics inhibit the hydrolysis of chloroprocaine by human serum.

T. Ludden, K. Haegele, J. McNay, 1978, Anesthesia and analgesia.

Simultaneous quantitation of disopyramide and its mono-dealkylated metabolite in human plasma by fused-silica capillary gas chromatography using nitrogen-phosphorus specific detection.

R. Kapil, C. Kerr, D. Edwards, 1984, Journal of chromatography.

Factors Influencing Procainamide Total Body Clearance in the Immediate Postmyocardial Infarction Period

D. Cannom, T. Ludden, D. Lalka, 1981, Journal of clinical pharmacology.

Displacement of lidocaine from serum alpha 1-acid glycoprotein binding sites by basic drugs.

R. Slaughter, D. Edwards, D. Lalka, 1983, European journal of clinical pharmacology.

Development of a bacteria-independent model of the multiple organ failure syndrome.

W. Flynn, S. Steinberg, D. Lalka, 1989, Archives of surgery.

Initial Experience of Clinical Pharmacology and Clinical Pharmacy Interactions in a Clinical Pharmacokinetics Consultation Service

R. G. Leonard, R. Talbert, A. Mclean, 1979, Journal of clinical pharmacology.

Mechanisms of nonlinear disposition kinetics of sulfamethazine

R. Slaughter, A. Mclean, P. Souich, 1979, Clinical pharmacology and therapeutics.

Sulfadiazine handling in the rabbit. II. Mechanisms of nonlinear kinetics of elimination.

A. Mclean, P. du Souich, J. McNay, 1978, The Journal of pharmacology and experimental therapeutics.

Tocainide kinetics and metabolism: Effects of phenobarbital and substrates for glucuronyl transferase

K. Stoeckel, A. Mclean, P. Souich, 1980, Clinical pharmacology and therapeutics.

Accumulation Kinetics of Propranolol in the Rat: Comparison of Michaelis– Menten-Mediated Clearance and Clearance Changes Consistent with the “Altered Enzyme Hypothesis”

K. Stoeckel, C. Weber, D. Lalka, 1994, Pharmaceutical Research.

The influence of vitamin K3 treatment on the pharmacokinetics and metabolism of (+)-propranolol in the rat.

H. Chow, D. Lalka, 1992, Drug Metabolism And Disposition.

Plasma clearance and tissue distribution of partially thiolated polycytidylic acid and its degradation products in rodents.

M. Kung, D. Lalka, Y. Ho, 1984, Cancer research.

Absolute drug bioavailability II: Evaluation of renal clearance perturbation method using literature data assuring a fraction absorbed of unity.

M. Gibaldi, A. Mclean, P. du Souich, 1978, Journal of pharmaceutical sciences.

Letter: Absolute drug bioavailability: approximation without comparison to parenteral dose for compounds exhibiting perturbable renal clearance.

D. Lalka, H. Feldman, 1974, Journal of pharmaceutical sciences.

Glutathione S-Transferase in Human Endometrium: Quantitation and Interindividual Variability in Isoform Content

Ping Li, D. Lalka, M. Sarkar, 1999, Gynecologic and Obstetric Investigation.

High-dose omeprazole: use of a multiple-dose study design to assess bioequivalence and accuracy of CYP2C19 phenotyping.

P. Kovacs, K. Stoeckel, D. Edwards, 1999, Therapeutic drug monitoring.

Differential effect of pentobarbital and chloralose in anesthetic doses on the serum protein binding of lidocaine in the dog.

J. Hassett, R. Slaughter, D. Edwards, 1988, Journal of pharmaceutical sciences.

The Hepatic First‐Pass Metabolism of Problematic Drugs

D Lalka, R K Griffith, C L Cronenberger, 1993, Journal of clinical pharmacology.

Estimation of tris(2-butoxyethyl) phosphate in biological fluids: novel intersubject variability in recovery from human serum.

G. Anderson, D. Lalka, A. Elvin, 1984, Journal of pharmaceutical sciences.

Factors Affecting Quinidine Protein Binding in Man

R. Slaughter, D. Edwards, D. Lalka, 1984, Journal of pharmaceutical sciences.

Lack of effect of treatment with human recombinant-tumour necrosis factor (HrTNF) on the binding of quinidine to alpha 1-acid glycoprotein (AGP).

D. Brenner, P. Creaven, D. Lalka, 1989, British Journal of Clinical Pharmacology.

Clinical Pharmacokinetics: Concepts and Applications. By Malcolm Rowland and Thomas N. Tozer. Lea & Febiger, 600 Washington Square, Philadelphia, Pa 19106. 1980. 331 Pp. 17 × 25 cm. Price U.S. $29.50 (canada $35.50)

D. Lalka, 1981 .

Lidocaine Clinical Pharmacokinetics

R. Slaughter, G. Anderson, D. Lalka, 1982, Drug intelligence & clinical pharmacy.

Procainamide Accumulation Kinetics in the Immediate Postmyocardial Infarction Period

D. Cannom, T. Ludden, D. Lalka, 1978, Journal of clinical pharmacology.